Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7320 p515
9 October 2004

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· Pharmacy education
· Primary care
· Community pharmacy
· Technicians
· Acute diverticulitis
· Oxygen
· Dispensing errors
· Charitable donations
· Returned medicines
· BPC
· Blood-brain barrier
· CPD
· Overseas membership
· The register
· Retention fee
· The Society
· The Journal


Letters to the Editor

BPC

Save Our Conference Club!

From Dr M. E. King, MRPharmS

Having just returned from the British Pharmaceutical Conference in Manchester I would like to draw the organisers’ attention to one small problem, namely the underlying social scene that a conference of this nature deserves. The problem arises from the “upmarketing” of the Conference Club.

Several years ago this was a venue for the poorer members of the conference to dance and socialise the night away and enabled them to meet other like-minded souls from all walks of the profession (and outside). It was a meeting place to start a night out or somewhere to regroup following a meal with close friends. It used to be a function room in a local pub or in the university. This year it was an empty room with no atmosphere in one of the most expensive hotels in town with a bottle of beer costing £3.20.

My solution: find premises with a 2am licence, organise a DJ or a small band to play, move the welcome reception there for the Sunday night so that everyone knows where it is and let nature take its course.

Come on conference organising committee, think of the conference goer without a company credit card and give the grass roots our social life back. If the Royal Pharmaceutical Society is serious about getting all sections of the profession united then what better place to start. If something is not sorted soon I may be forced to start a campaign (SOCC, I think).

Martin King
Cardiff

Send your letter to The Editor

Previous Topic (Returned medicines)
Next Topic (Blood-brain barrier)

Back to Top


©The Pharmaceutical Journal